Castle Biosciences, Inc. (CSTL)
NASDAQ · Healthcare
Castle Biosciences, Inc. Net Income 2018–2025
Castle Biosciences, Inc. annual/quarterly net income history and growth rate from 2018 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Castle Biosciences, Inc. net income for the quarter ending March 31, 2026 was -14.5 M, a 43.82% decrease year-over-year.
- Castle Biosciences, Inc. net income for the twelve months ending March 31, 2026 was -36.3 M, a 2177.03% decrease year-over-year.
- Castle Biosciences, Inc. annual net income for 2025 was -24.2 M, a 232.41% decrease from 2024.
- Castle Biosciences, Inc. annual net income for 2024 was 18.2 M, a 131.75% decrease from 2023.
- Castle Biosciences, Inc. annual net income for 2023 was -57.5 M, a 14.41% decrease from 2022.
- Castle Biosciences, Inc. annual net income for 2022 was -67.1 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Castle Biosciences, Inc. Net Income — FAQ
Castle Biosciences, Inc. (CSTL) net income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Castle Biosciences, Inc.'s net income?
Castle Biosciences, Inc. (CSTL) reported net income of -$24M for fiscal 2025.
Where can I see CSTL's net income history?
The chart and table above show Castle Biosciences, Inc.'s net income by year and by quarter, including the growth rate.